| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| GS-9620 |
|
1228585-88-3 |
詳細(xì)
|
| SRT-2104 |
|
1093403-33-8 |
詳細(xì)
|
| AZD7986 |
|
1802148-05-5 |
詳細(xì)
|
| GBT-440 |
|
1446321-46-5 |
詳細(xì)
|
| CPI-637 |
|
1884712-47-3 |
詳細(xì)
|
| XL-147(SAR245408) |
|
956958-53-5 |
詳細(xì)
|
| EPZ-015938 (GSK3326595) |
|
1616392-22-3 |
詳細(xì)
|
| MKC-3946 |
|
1093119-54-0 |
詳細(xì)
|
| ORM-15341 |
|
1297537-33-7 |
詳細(xì)
|
| GSK-2256098 |
|
1224887-10-8 |
詳細(xì)
|
| UK-371804 (Urokinase inhitibor 1） |
|
256477-09-5 |
詳細(xì)
|
| UNC1215 |
|
1415800-43-9 |
詳細(xì)
|
| Pexidartinib (PLX3397) |
|
1029044-16-3 |
詳細(xì)
|
| CP-609754 (OSI754) |
|
1190094-64-4 |
詳細(xì)
|
| Fevipiprant |
|
872365-14-5 |
詳細(xì)
|
| Bay-876 |
|
1799753-84-6 |
詳細(xì)
|
| Lasmiditan |
|
439239-90-4 |
詳細(xì)
|
| GDC-0084 |
|
1382979-44-3 |
詳細(xì)
|
| Acebilustat |
|
943764-99-6 |
詳細(xì)
|
| 1-methyl-3-amino-4-cyanopyrazole |
|
21230-50-2 |
詳細(xì)
|
| SH5-07 (SH-5-07) |
|
1456632-41-9 |
詳細(xì)
|
| AMG-3969 |
|
1361224-53-4 |
詳細(xì)
|
| Grapiprant |
|
415903-37-6 |
詳細(xì)
|
| ETP-46321 |
|
1252594-99-2 |
詳細(xì)
|
| SUN11602 |
|
704869-38-5 |
詳細(xì)
|
| STK16-IN-1 |
|
1223001-53-3 |
詳細(xì)
|
| Binimetinib |
|
606143-89-9 |
詳細(xì)
|
| NVS-PAK1-1 |
|
1783816-74-9 |
詳細(xì)
|
| ABBV-075 |
|
1445993-26-9 |
詳細(xì)
|
| BP-1-102 |
|
1334493-07-0 |
詳細(xì)
|
| RAF-709 |
|
1628838-42-5 |
詳細(xì)
|
| Lasmiditan hydrochloride |
|
613677-28-4 |
詳細(xì)
|
| Lasmiditan hemisuccinate |
|
439239-92-6 |
詳細(xì)
|
| GNE-3511 |
|
1496581-76-0 |
詳細(xì)
|
| NIBR189 |
|
1599432-08-2 |
詳細(xì)
|
| MMAE |
一甲基澳瑞他汀E |
474645-27-7 |
詳細(xì)
|
| Coumestrol |
香豆雌酚 |
479-13-0 |
詳細(xì)
|
| SPD304 |
|
869998-49-2 |
詳細(xì)
|
| AB-928 |
3-(2-氨基-6-(1-((6-(2-羥丙基)吡啶-2-基)甲基)-1H-1,2,3-三唑-4-基)嘧啶-4-基)-2-甲基苯腈 |
2239273-34-6 |
詳細(xì)
|
| ONO-7475 |
|
1646839-59-9 |
詳細(xì)
|
| 1-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)piperidine-4-carbaldehyde |
|
2241315-66-0 |
詳細(xì)
|
| Mitapivat |
|
1260075-17-9 |
詳細(xì)
|
| Rucaparib(AG-014699) |
瑞卡帕布（AG-014699） |
459868-92-9 |
詳細(xì)
|
| ND-630 |
|
1434635-54-7 |
詳細(xì)
|
| N-((3R,4R)-4-fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidin-3-yl)acrylamide |
|
1776112-90-3 |
詳細(xì)
|
| Quetiapinehemifumaratesalt |
富馬酸喹硫平 |
111974-72-2 |
詳細(xì)
|
| NKY 80 |
化合物 T16333 |
299442-43-6 |
詳細(xì)
|
| AB-680 |
|
2105904-82-1 |
詳細(xì)
|
| Ramelteon |
雷美替胺 |
196597-26-9 |
詳細(xì)
|
| (S)-1-amino-3-(3,4-dihydroisoquinolin-2(1H)-yl)propan-2-ol |
(S)-1-氨基-3-(3,4-二氫異喹啉-2(1H) - 基)丙-2-醇 |
1616077-51-0 |
詳細(xì)
|
| INF 4E |
|
88039-46-7 |
詳細(xì)
|
| NKP-1339 |
|
197723-00-5 |
詳細(xì)
|
| BS-181 HCl |
|
1397219-81-6 |
詳細(xì)
|
| Dexmedetomidine hydrochloride |
鹽酸右美托咪定 |
145108-58-3 |
詳細(xì)
|
| Ceapin-A7 |
N-(1-(2,4-雙(三氟甲基)芐基)-1H-吡唑-4-基)-5-(呋喃-2-基)異惡唑-3-甲酰胺 |
2323027-38-7 |
詳細(xì)
|
| NCT-501 |
|
1802088-50-1 |
詳細(xì)
|
| NNC 55-0396 |
|
357400-13-6 |
詳細(xì)
|
| Rezivertinib(BPI-7711) |
|
1835667-12-3 |
詳細(xì)
|
| Rucaparib |
瑞卡帕布 |
283173-50-2 |
詳細(xì)
|
| 2'-Deoxyadenosine monohydrate |
|
16373-93-6 |
詳細(xì)
|
| Afimoxifene |
|
68392-35-8 |
詳細(xì)
|
| Erucin |
三芥子酸甘油酯 |
4430-36-8 |
詳細(xì)
|
| DL-Sulforaphane |
|
4478-93-7 |
詳細(xì)
|
| 2'-Deoxy-2'-fluoroguanosine |
|
78842-13-4 |
詳細(xì)
|
| 2'-Deoxyuridine |
|
951-78-0 |
詳細(xì)
|
| 2'-Deoxy-2'-fluoroinosine |
|
80049-87-2 |
詳細(xì)
|
| Dansylsarcosine piperidiniuM salt |
|
72517-44-3 |
詳細(xì)
|
| 2,6-Dibromopyridine-4-carboxylic acid |
|
2016-99-1 |
詳細(xì)
|
| 1H-Pyrrolo[2,1-c][1,4]benzodiazepine-3,11(2H,11aH)-dione, 5,10-dihydro-, (11aS)- |
|
865430-51-9 |
詳細(xì)
|
| 2'-Fluoro-2'-deoxyuridine |
|
784-71-4 |
詳細(xì)
|
| 11H-Pyrrolo[2,1-c][1,4]benzodiazepin-11-one, 1,2,3,5,10,11a-hexahydro-, (11aR)- |
|
933981-46-5 |
詳細(xì)
|
| 2'-deoxyinosine |
|
890-38-0 |
詳細(xì)
|
| 2'-Deoxycytidine |
|
951-77-9 |
詳細(xì)
|
| 2'-O-Methyluridine |
|
2140-76-3 |
詳細(xì)
|
| 2'-Fluoro-2'-Deoxycytidine |
|
10212-20-1 |
詳細(xì)
|
| 2'-Fluoro-2'-deoxyadenosine |
|
64183-27-3 |
詳細(xì)
|
| 2'-OMe Cytidine |
|
2140-72-9 |
詳細(xì)
|
| Nω-Hydroxy-nor-L-Arginine Dihydrochloride |
|
291758-32-2 |
詳細(xì)
|
| Fluorofurimazine |
|
2412089-96-2 |
詳細(xì)
|
| GSK2982772 |
|
1622848-92-3 |
詳細(xì)
|
| PFI-90 |
|
53995-62-3 |
詳細(xì)
|
| 1H-Pyrrolo[2,1-c][1,4]benzodiazepine-3,11(2H,11aH)-dione, 7-bromo-5,10-dihydro-, (11aS)- |
|
1378239-53-2 |
詳細(xì)
|
| Florfenicol Impurity 2 |
|
2293206-33-2 |
詳細(xì)
|
| Kinase inhibitor 1 |
|
2135696-72-7 |
詳細(xì)
|
| CP-21R7 |
|
125314-13-8 |
詳細(xì)
|
| UT-155 |
|
2031161-35-8 |
詳細(xì)
|
| 1H-Pyrrolo[2,1-c][1,4]benzodiazepine-3,11(2H,11aH)-dione, 7-chloro-5,10-dihydro-, (11aS)- |
|
1581274-41-0 |
詳細(xì)
|
| 1H-Pyrrolo[2,1-c][1,4]benzodiazepine-3,11(2H,11aH)-dione, 7-bromo-5,10-dihydro-, (11aR)- |
|
1581274-43-2 |
詳細(xì)
|
| Pyrrolo[2,1-b]quinazoline-1-carboxylic acid, 1,2,3,9-tetrahydro-, (1S)- |
|
481710-98-9 |
詳細(xì)
|
| 11H-Pyrrolo[2,1-c][1,4]benzodiazepin-11-one, 1,2,3,5,10,11a-hexahydro-, (11aS)- |
|
55661-84-2 |
詳細(xì)
|
| 1H-Pyrrolo[2,1-c][1,4]benzodiazepine-3,11(2H,11aH)-dione, 7-chloro-5,10-dihydro-, (11aR)- |
|
1581274-42-1 |
詳細(xì)
|
| 2,6-diaminopurine 2'-deoxyriboside |
|
4546-70-7 |
詳細(xì)
|
| 3-Methylenehexanoicacid |
|
4380-89-6 |
詳細(xì)
|
| 2-(2,6-dioxopiperidin-3-yl)-5-(4-(hydroxymethyl)piperidin-1-yl)isoindoline-1,3-dione |
|
2229717-49-9 |
詳細(xì)
|
| AG-7404 |
|
343565-99-1 |
詳細(xì)
|
| DRV1 (GPR32) agonist C2A |
|
862811-76-5 |
詳細(xì)
|
| Selgantolimod |
|
2004677-13-6 |
詳細(xì)
|
| Pexidartinib (PLX3397) HCl |
|
|
詳細(xì)
|
| 1H-Pyrrolo[2,1-c][1,4]benzodiazepine-3,11(2H,11aH)-dione, 5,10-dihydro-, (11aR)- |
|
2254419-02-6 |
詳細(xì)
|
| Pyrrolo[2,1-b]quinazoline-1-carboxylic acid, 1,2,3,9-tetrahydro-, (1R)- |
|
2220162-30-9 |
詳細(xì)
|